Log in
Enquire now
‌

US Patent 9447194 Bispecific chimeric antigen receptors and encoding polynucleotides thereof

Patent 9447194 was granted and assigned to Seattle Children's on September, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Seattle Children's
Seattle Children's
Date Filed
February 13, 2013
Date of Patent
September 20, 2016
Patent Applicant
Seattle Children's
Seattle Children's
Patent Application Number
14376610
Patent Citations Received
‌
US Patent 12122846 Chimeric antigen receptor for tumor targeting
0
‌
US Patent 12005081 Chimeric receptors and methods of use thereof
0
‌
US Patent 12060585 Expression of novel cell tags
0
‌
US Patent 12091459 Bispecific chimeric antigen receptors, encoding polynucleotides and use of receptors thereof to treat cancer
0
‌
US Patent 11701384 Methods and compositions involving interleukin-6 receptor alpha-binding single chain variable fragments
0
‌
US Patent 11759480 Compositions and methods for CAR T cell therapy
‌
US Patent 11779602 Methods of use for CAR T cells
‌
US Patent 11787848 CD33 specific chimeric antigen receptors
‌
US Patent 11802163 Chimeric antigen receptors targeting glypican-3 or mesothelin
‌
US Patent 11840575 Engineered immune cells targeting BCMA and their uses thereof
0
•••
Patent Inventor Names
Michael Jensen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9447194
Patent Primary Examiner
‌
Robert Landsman

Find more entities like US Patent 9447194 Bispecific chimeric antigen receptors and encoding polynucleotides thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.